Apogee Therapeutics Inc. APGE
$85.21
▼ -1.31% 24H
About
Apogee Therapeutics Inc. is a clinical-stage biotechnology company developing differentiated biologics for inflammatory and immune diseases. It focuses on advancing novel antibody therapeutics targeting well-established biological drivers to address conditions with high unmet needs, including atopic dermatitis, chronic…
SectorHealthcare
ExchangeNASDAQ
IndustryBiotechnology
CountryUnited States
Employees261
TickerAPGE
Statistics
Market Cap$6.38B
Revenue (TTM)$0
Net Income-$255.8M
Net Margin—
EPS$-3.74
P/E-23.87
P/S—
P/B5.04
EV/EBITDA-17.52
ROE-28.5%
Dividend Yield—
Price$85.21
Data: Twelve Data · Revenue = mcap / P/S